CClinicalTrials.gg
Status unknownNCT05203978Updated Mar 8, 2022

Virtual Reality Colonoscopy : a Study From Nancy

An observational study in Colorectal Neoplasms and Colorectal Polyp, sponsored by Central Hospital, Nancy, France. Status unknown. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-03-08.

Sponsored by Central Hospital, Nancy, France · Observational

The sponsor has not verified this record recently (last verified Feb 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
120
Ages
18 Years and older
Sex
All
01

Study summary

Colonoscopy is an exam which can be responsible for pain and discomfort for the patient.

Therefore colonoscopy is performed most of the time under general anaesthesia. Moreover, drug-induced sedation comes with adverse effects especially among fragile patients.

Besides, monitoring patients during and after sedation is both logistically demanding and costly.

Virtual reality offers immersive and three dimensional experiences that distract the attention and might improve patients comfort.

The aim of the study is to investigate the use of virtual reality during colonoscopy versus general anaesthesia.

Read the detailed description

The study is based on a home made questionnaires completed by the operator and the patient before and after the colonoscopy.

02

Conditions studied

  • Colorectal Neoplasms
  • Colorectal Polyp
03

In context

Colorectal Neoplasms

5,599 studies on the registry are indexed under Colorectal Neoplasms; 1,459 are open to participants now.

This study's planned enrollment of 120 is below the median of 250 across 1,226 observational studies indexed under Colorectal Neoplasms.

Browse Colorectal Neoplasms studies →

Lead sponsor

Central Hospital, Nancy, France is the lead sponsor of 778 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Adult patient needed planned colonoscopy and able to fill in questionnaires in French

Inclusion criteria

  • patient needed planned colonoscopy
  • able to fill in questionnaires in French

Exclusion criteria

Exclusion Criteria:

  • visual or auditor impairments
  • dementia patient
  • limited French language skills
  • diagnosis of balance disorders or epilepsy
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
120 participants (estimated)
Patient registry
No

Groups and cohorts

  • Virtual reality colonoscopy

    using virtual reality with glasses and sound no anaesthesia

    Procedure: colonoscopy

  • General anaesthesia colonoscopy

    gold standard

    Procedure: colonoscopy

Interventions

  • Procedurecolonoscopy

    Colonoscopy

06

What researchers measure

Primary outcomes

  1. Complete colonoscopy defined by caecum intubation (binary criterion : yes or no)

    found of the report

    Time frame: baseline

Secondary outcomes

  1. Pain evaluated by Numeric Rating Scale during the procedure (0 no pain and 10 highest imaginable pain)

    asked on the questionnaire

    Time frame: baseline

  2. Anxiety evaluated by the validated score State Trait Anxiety Inventory ranging from 20 (absence of anxiety) to 80 (highest anxiety)

    asked on the questionnaire

    Time frame: baseline

  3. Comfort evaluated by Gloucester Comfort Scale between 1 comfortable and 5 severe discomfort

    asked on the questionnaire

    Time frame: baseline

  4. Satisfaction evaluated on scale of willingness to return (0 no willing at all to 10 definitively willing)

    asked on the questionnaire

    Time frame: baseline

  5. Polyp removal (binary criterion : yes or no)

    found on the report

    Time frame: baseline

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 8, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05203978
Lead sponsor
Central Hospital, Nancy, France
Responsible party
Jean-Baptiste CHEVAUX (Hospital practitioner, Central Hospital, Nancy, France) — Principal investigator
First posted
Jan 24, 2022
Start date
Mar 2022 (estimated)
Primary completion
Mar 2022 (estimated)
Completion
Jun 2022 (estimated)
Last update
Mar 8, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion